Stefanie Rungaldier is a highly experienced medical advisor and scientist, currently serving as the Medical Advisor for Clinical Development at Miltenyi Biomedicine since April 2023. Previously, Rungaldier worked at Bristol Myers Squibb as a Disease Area Specialist in Hematology, CAR T, and Immunology, contributing to prelaunch activities and clinical studies. Rungaldier has extensive experience as a Medical Science Liaison in oncology, with notable roles at Nordic Nanovector ASA and Shire, focusing on radioimmunotherapy and scientific collaboration with healthcare professionals. Rungaldier's academic background includes multiple post-doctoral positions at esteemed universities, emphasizing project and lab management, along with an extensive education in virology and tumor biology, culminating in a doctorate from Vetmeduni.